Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3<i>H-</i>quinazolin-4-one derivatives
作者:Nahed N. E. El-Sayed、Norah M. Almaneai、Abir Ben Bacha、Omar Al-Obeed、Rehan Ahmad、Maha Abdulla、Ahmed M. Alafeefy
DOI:10.1080/14756366.2019.1574780
日期:2019.1.1
Abstract Some new 3H-quinazolin-4-one derivatives were synthesised and screened for anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities. Compound 15d was more potent in reducing the cell viabilities of HT-29 and SW620 cells lines to 38%, 36.7%, compared to 5-FU which demonstrated cell viabilities of 65.9 and 42.7% respectively. The IC50 values of 15d were ∼20 µg/ml
摘要 合成并筛选了一些新的 3 H-喹唑啉-4-酮衍生物,其具有抗癌、抗磷脂酶、抗蛋白酶和抗代谢综合征活性。与显示细胞活力分别为65.9%和42.7%的5-FU相比,化合物15d更有效地将HT-29和SW620细胞系的细胞活力降低至38%、36.7% 。15d的IC 50值为~20 µg/ml。细胞凋亡活性评估显示,15d通过下调 Bcl2 和 BclxL 降低了细胞活力。此外,化合物8j、8d / 15a / 15e、5b和8f针对hGV、hG-X、NmPLA 2和AmPLA 2的促炎亚型显示出比齐墩果酸更低的IC 50值。此外,8d、8h、8j、15a、15b、15e和15f表现出比槲皮素更好的抗α-淀粉酶活性,而8g、8h和8i表现出比别嘌呤醇更高的抗α-葡萄糖苷酶活性。因此,这些化合物可以被认为是潜在的抗糖尿病药。最后,没有一种化合物表现出比所用参考药物更高的抗蛋白酶或黄嘌呤氧化酶活性。